EyeWise Diagnostics
About
What does EyeWise Diagnostics do?
EyeWise Diagnostics is developing a novel technology for the early detection and tracking of neurodegenerative and cardiovascular diseases. Their non-invasive eye examination device aims to identify early signs of conditions such as Alzheimer's Disease (AD), Age-related Macular Degeneration (AMD), Computer Vision Syndrome (CVS), and CardioVascular Disease.
What is EyeWise Diagnostics's revenue?
StartupHub estimates EyeWise Diagnostics's annual revenue at $1.2M (range $987K to $2.8M, 68% confidence), based on comparable companies in the sector.
Where is EyeWise Diagnostics headquartered?
EyeWise Diagnostics is headquartered in Tel Aviv, Israel.
When was EyeWise Diagnostics founded?
EyeWise Diagnostics was founded in 2017.
What industry does EyeWise Diagnostics operate in?
EyeWise Diagnostics operates in Healthcare, Optometry, Non-invasive, Examination, HealthTech, MedTech.
How many employees does EyeWise Diagnostics have?
EyeWise Diagnostics has approximately 6 people on record.
What is EyeWise Diagnostics's current status?
EyeWise Diagnostics's current operating status is: Inactive.
An entrant is a company tagged Healthcare whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.